REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Fictile Pharma Bt. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: FICTILE PHARMA Gyogyszertar es Kereskedelmi Bt. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

Fictile Pharma Bt. is a company based in Hungary, with its head office in Debrecen. It operates in the Pharmacies and Drug Stores industry. It was established on December 01, 1995. Fictile Pharma Bt. currently employs 19 (2024) people. From the latest financial highlights, Fictile Pharma Bt. reported a net sales revenue increase of 22.42% in 2023. During that time, Fictile Pharma Bt.’s total assets grew by 47.68%. In 2023, Fictile Pharma Bt.’s net profit margin increased by 2.47%.

Headquarters
Csapo utca 22. fszt. 2.
Debrecen; Hajdu-Bihar; Postal Code: 4029

Contact Details: Purchase the Fictile Pharma Bt. report to view the information.

Website: http://www.levendulapatikadebrecen.gyogyszer.hu

Basic Information
Total Employees:
Purchase the Fictile Pharma Bt. report to view the information.
Outstanding Shares:
Purchase the Fictile Pharma Bt. report to view the information.
Registered Capital:
Purchase the Fictile Pharma Bt. report to view the information.
Financial Auditors:
Purchase the Fictile Pharma Bt. report to view the information.
Incorporation Date:
December 01, 1995
Key Executives
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Fictile Pharma Bt. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
22.42%▲
Total operating revenue
22.43%▲
Operating profit (EBIT)
541.09%▲
EBITDA
345.41%▲
Net Profit (Loss) for the Period
922.6%▲
Total assets
47.68%▲
Total equity
12.46%▲
Operating Profit Margin (ROS)
2.62%▲
Net Profit Margin
2.47%▲
Return on Equity (ROE)
10.84%▲
Quick Ratio
0.01%▲
Cash Ratio
0.03%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo